Jobs
-
All levels of Scientists are needed in the Inhalation Department at Catalent Pharma Solutions’ Morrisville, NC facility. Catalent Pharma Solutions (a Blackstone Group company) is a leading Drug Development, Advanced Delivery Technology and Supply partner… Read more . . .
-
Smartinhaler developer Nexus6 has raised NZ$1.6 million (US$1.34 million) from existing investors plus NZ$3 (US$2.5 million) from BioScience Managers, with additional funding expected to bring the total to NZ$5 million by the close of the… Read more . . .
-
According to North Carolina-based Cornerstone Therapeutics, Chiesi Farmaceutici has offered to purchase shares of Cornerstone’s common stock for between $6.40 and $6.70 per share, to take the company private. Chiesi already owns approximately 60% of… Read more . . .
-
With the rapid growth of OINDP research and manufacturing throughout Asia over the past few years, a group of inhalation specialists from the UK, Australia, India, and China decided that the time was right to… Read more . . .
-
According to GSK and Theravance, the FDA has accepted their NDA for the Anoro Ellipta umeclidinium bromide (UMEC)/vilanterol (VI) dry powder inhaler for the treatment of COPD, with a PDUFA date of December 18, 2013.… Read more . . .
-
CRO Quintiles says that it has filed a registration statement with the US. Securities and Exchange Commission (SEC) for an initial public offering (IPO) of an undisclosed number of shares of common stock. The company… Read more . . .
-
The American Association for Laboratory Accreditation (A2LA) has accredited Next Breath, LLC, to ISO (the International Organization for Standardization) and IEC (the International Electrotechnical Commission) 17025:2005a, the primary standard for testing and calibration labs. Next… Read more . . .
-
Discovery Laboratories says that Deerfield Management Company will provide the company up to $30 million in the form of a secured loan facility. Discovery Labs will use the money for development and commercialization of its… Read more . . .
-
According to Critical Pharmaceuticals, a Phase 1b study has shown that its CP024 dry powder intranasal human growth hormone (hGH) was well tolerated with only a few minor adverse effects and showed a linear dose… Read more . . .
-
MeadWestvaco has announced a $7.5 million expansion of its pharmaceutical manufacturing Centre of Excellence in Hemer, Germany, an expansion the company attributes largely to growth in the preservative-free nasal product market. According to the company,… Read more . . .
Featured event:
Upcoming Events
Sponsored by Intertek,, hosts of
The Inhaled & Nasal Biologics | DNA Forum
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
July 13-July 16: 2026 ISAM Congress, Taipei, Taiwan
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK